ESTRO 35 Abstract-book

Tumour targeting - considering normal tissue biology (Abs. 98-101)

Debate

This house believes that progress in the treatment of locally advanced NSCLC will come from: (Abs. 102-103)

Symposium

Active surveillance for low risk prostate cancer: to treat or not to treat? (Abs. 104-106)

Achieving excellence in image guided brachytherapy (Abs. 107-109)

Imaging markers for response prediction and assessment (Abs. 110-112)

Debate

There are many existing IGRT options for highly accurate dose delivery. Is there a need for large-scale in-room MR-guidance? (Abs. 113-114)

Symposium

Additional tools for contouring (Abs. 115-117)

Poster Viewing

3: Clinical: Gastrointenstinal and gynaecology (Abs. 118-125)

Joint Symposium

ESTRO-ESR: MR-PET (Abs. 126-128)

Proffered Papers

Radiobiology 2: Interplay between cancer stem cells ,hypoxia and the radiation response (Abs. 129-134)

Clinical 3: Lung (Abs. 135-140)

Clinical 4: Late breaking abstracts (Abs. 141-146)

Brachytherapy 2: EYE GI (Abs. 147-152)